What is 5,7-dihydro-2-methylthieno(3,4-d)pyrimidine?
5,7-dihydro-2-methylthieno(3,4-d)pyrimidine is a synthetic flavoring compound identified by CAS Number 36267-71-7. It is a heterocyclic organic molecule containing both sulfur and nitrogen atoms in its ring structure. This compound falls within the broader category of synthetic flavoring agents that are designed to enhance or modify the taste and aroma profile of food and beverage products. The specific molecular structure of this compound allows it to interact with taste and smell receptors, contributing organoleptic properties to formulated foods.
Common Uses
As a flavoring agent, 5,7-dihydro-2-methylthieno(3,4-d)pyrimidine is used in very small quantities in various food applications. Synthetic flavoring compounds of this type are typically employed in processed foods, beverages, dairy products, confectionery, and savory products where specific flavor notes are desired. The compound would be used at levels consistent with flavoring industry standards, which are generally measured in parts per million (ppm). Like other synthetic flavorings, it is formulated to provide particular taste characteristics that may be difficult or economically unfeasible to obtain through natural flavor extraction.
Safety Assessment
The safety profile of 5,7-dihydro-2-methylthieno(3,4-d)pyrimidine has not been extensively documented in publicly available scientific literature. The compound has not received FDA GRAS (Generally Recognized as Safe) designation. However, it is important to note that the absence of GRAS status does not automatically indicate a safety concernโrather, it indicates that the manufacturer has not pursued or completed the GRAS notification process through the FDA.
According to FDA records available through AdditiveFacts, there have been zero reported adverse events associated with this additive and zero product recalls linked to it. This absence of adverse event reports suggests that if the compound is used in food products, it has not generated consumer safety complaints or regulatory concerns to date.
Toxicological evaluation of synthetic flavoring compounds typically examines acute toxicity, chronic toxicity, genotoxicity, and reproductive/developmental effects. The specific toxicological profile of this particular compound would require consultation of proprietary safety dossiers or published peer-reviewed studies, which may be limited in the public domain.
Regulatory Status
In the United States, this compound has not achieved FDA GRAS status. This means it does not appear on the FDA's GRAS notification list and cannot be legally marketed as GRAS for its intended use without proper regulatory approval or submission. To be legally used as a food additive in the United States, it would require either GRAS notification acceptance or formal FDA food additive petition approval, which would include comprehensive safety data submission.
The regulatory status in other jurisdictions, including the European Union and other countries, would need to be evaluated separately, as regulatory frameworks and approved additive lists vary by region. The EU maintains its own approved flavoring substances list, which does not necessarily align with FDA determinations.
Key Studies
Publicly available peer-reviewed literature on 5,7-dihydro-2-methylthieno(3,4-d)pyrimidine specifically is limited. For synthetic flavoring agents of this chemical class, safety assessment typically relies on submission of safety data to regulatory bodies during the approval process. Such data may include ADME (absorption, distribution, metabolism, excretion) studies, toxicology studies, and structural alerts assessments conducted according to JECFA (Joint FAO/WHO Expert Committee on Food Additives) or similar international guidelines. Without access to proprietary safety dossiers or published peer-reviewed studies, comprehensive scientific assessment of this specific compound remains limited in the public domain. Manufacturers or researchers seeking detailed safety information would need to consult original safety submissions or contact the compound's developer directly.